NO933423L - Modifisert blodplate-faktor-4 - Google Patents

Modifisert blodplate-faktor-4

Info

Publication number
NO933423L
NO933423L NO933423A NO933423A NO933423L NO 933423 L NO933423 L NO 933423L NO 933423 A NO933423 A NO 933423A NO 933423 A NO933423 A NO 933423A NO 933423 L NO933423 L NO 933423L
Authority
NO
Norway
Prior art keywords
platelet factor
mpf
cpf
modified platelet
factor
Prior art date
Application number
NO933423A
Other languages
English (en)
Norwegian (no)
Other versions
NO933423D0 (no
Inventor
Shalley Kant Gupta
Jai Pal Singh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO933423D0 publication Critical patent/NO933423D0/no
Publication of NO933423L publication Critical patent/NO933423L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
NO933423A 1992-09-25 1993-09-24 Modifisert blodplate-faktor-4 NO933423L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95279792A 1992-09-25 1992-09-25

Publications (2)

Publication Number Publication Date
NO933423D0 NO933423D0 (no) 1993-09-24
NO933423L true NO933423L (no) 1994-03-28

Family

ID=25493243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933423A NO933423L (no) 1992-09-25 1993-09-24 Modifisert blodplate-faktor-4

Country Status (24)

Country Link
US (3) US5512550A (es)
EP (1) EP0589719B1 (es)
JP (1) JPH06220091A (es)
KR (1) KR940007059A (es)
CN (1) CN1035257C (es)
AT (1) ATE151777T1 (es)
AU (1) AU665114B2 (es)
BR (1) BR9303903A (es)
CA (1) CA2106629A1 (es)
CZ (1) CZ195193A3 (es)
DE (1) DE69309827T2 (es)
DK (1) DK0589719T3 (es)
ES (1) ES2101237T3 (es)
FI (1) FI934183A7 (es)
GR (1) GR3023356T3 (es)
HK (1) HK100597A (es)
HU (1) HUT69928A (es)
IL (1) IL107040A0 (es)
MX (1) MX9305901A (es)
MY (1) MY109158A (es)
NO (1) NO933423L (es)
NZ (1) NZ248724A (es)
YU (1) YU61893A (es)
ZA (1) ZA936925B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4
CA2148301A1 (en) * 1994-05-09 1995-11-10 Rama Belagaje Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
US5994292A (en) * 1995-05-31 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
JPH09143199A (ja) * 1995-11-17 1997-06-03 Nippon Chem Res Kk 血小板第４因子の製造方法
CN100389126C (zh) * 1995-12-13 2008-05-21 儿童医学中心公司 内皮细胞增殖抑制剂及其应用方法
FR2774990B1 (fr) * 1998-02-16 2000-07-28 Inst Vaisseaux Et Du Sang Nouveaux peptides, utilisation en therapeutique et compositions pharmaceutiques les renfermant
CZ307433B6 (cs) 2001-09-12 2018-08-22 Leadiant Biosciences Sa Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
US20090011981A1 (en) * 2004-09-15 2009-01-08 K.U. Leuven Research & Development Novel Inhibitors of Angiogenesis
CN114805536B (zh) * 2022-06-24 2022-09-02 北京百臻生物技术有限公司 一种人血小板因子4蛋白突变体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US4737580A (en) * 1985-03-15 1988-04-12 Oncogen Platelet related growth regulator
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5187075A (en) * 1989-01-26 1993-02-16 Sri International Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
US5112946A (en) * 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
EP0423641A3 (en) * 1989-10-18 1992-01-15 Nippon Mining Company Limited Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or tgfalpha
WO1992002240A2 (en) * 1990-07-27 1992-02-20 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Also Published As

Publication number Publication date
EP0589719B1 (en) 1997-04-16
US5935928A (en) 1999-08-10
HK100597A (en) 1997-08-08
DE69309827T2 (de) 1997-08-28
DK0589719T3 (da) 1997-09-08
NO933423D0 (no) 1993-09-24
KR940007059A (ko) 1994-04-26
AU665114B2 (en) 1995-12-14
MY109158A (en) 1996-12-31
US5512550A (en) 1996-04-30
GR3023356T3 (en) 1997-08-29
US5538949A (en) 1996-07-23
MX9305901A (es) 1994-05-31
BR9303903A (pt) 1994-06-14
FI934183L (fi) 1994-03-26
YU61893A (sh) 1996-02-19
ATE151777T1 (de) 1997-05-15
CZ195193A3 (en) 1994-04-13
NZ248724A (en) 1995-10-26
CN1035257C (zh) 1997-06-25
FI934183A0 (fi) 1993-09-24
CA2106629A1 (en) 1994-03-26
JPH06220091A (ja) 1994-08-09
EP0589719A1 (en) 1994-03-30
FI934183A7 (fi) 1994-03-26
ES2101237T3 (es) 1997-07-01
ZA936925B (en) 1995-03-20
AU4757393A (en) 1994-03-31
IL107040A0 (en) 1993-12-28
HUT69928A (en) 1995-09-28
CN1088216A (zh) 1994-06-22
DE69309827D1 (de) 1997-05-22
HU9302687D0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
Tschesche et al. Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment.
KR102236805B1 (ko) Hc-ha/ptx3 복합체를 함유하는 조성물 및 이의 사용 방법
KR0180918B1 (ko) 혈소판 응집 저해제
López-Pedrera et al. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome
BR9814276A (pt) Antìgenos de superfìcie
DE69232636D1 (de) CNP-Analoge Peptide und ihre Verwendung
NO20081654L (no) Stabiliserte GLP-1-analoger
PH12021550789A1 (en) Disulfide bond stabilized polypeptide compositions and methods of use
MX2022014506A (es) Cisteina proteasa.
SE0301431D0 (sv) Novel antimicrobial peptides
DK0589719T3 (da) Modificeret blodpladefaktor-4
DE69737766D1 (de) Zusammensetzungen von stammzellfaktor (scf)-analogen und auf diese bezogene verfahren
Pellerin et al. Corticotropin-induced secreted protein, an ACTH-induced protein secreted by adrenocortical cells, is structurally related to thrombospondins.
ATE449790T1 (de) Rekombinante gelatinepartikel für die zelladhäsion
DE69428041D1 (de) Inhibierung von Leukozytenadhäsion
Pellerin et al. The molecular structure of corticotropin-induced secreted protein, a novel member of the thrombospondin family.
JP2009536821A (ja) 新規血栓溶解分子及びその製造法
Slager et al. Organization of non-muscle myosin during early murine embryonic differentiation
Wang et al. Plants as a valuable source of bioactive peptides
ATE390481T1 (de) Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren
WO2024030898A3 (en) Compositions and methods for evaluating microtubule dynamics
Hana et al. Endothelial differentiation of Wharton’s Jelly-derived mesenchymal stem cells seeded on chitosan/hyaluronan multilayer films
US6083914A (en) Antithrombotic peptides
WO2000034441A1 (en) CONVERSION OF LAMININ 5 TO A MIGRATORY SUBSTRATE BY PROTEOLYSIS OF THE η2 CHAIN THEREOF
WO2003093787A3 (en) Antiproliferative protein from hypericum perforatum and nucleic acids encoding the same